Parameters | Beijing genotype, n (%) | Non- Beijing genotypes, n (%) | Odds Ratio (OR) | p-value* | 95% CI |
---|---|---|---|---|---|
Sex | |||||
 Male (250) | 41 (53.95) | 211 (69.18) | 0.522 | 0.01 | 0.312–0.871 |
 Female (131) | 35 (46.05) | 94 (30.82) |  |  |  |
Age group | |||||
  < 15 (11) | 4 (5.26) | 7 (2.3) | 2.295 | 0.1 | 0.650–8.106 |
 15–44 (290) | 58 (76.32) | 233 (76.39) |  |  |  |
  ≥ 45 (80) | 14 (18.42) | 65 (21.31) | 1.155 | 0.6 | 0.606–2.203 |
HIV Status | |||||
 Sero positive (38) | 8 (10.53) | 30 (9.83) | 1.078 | 0.8 | 0.473–2.458 |
 Sero negative (343) | 68 (89.47) | 275 (90.16) |  |  |  |
Site of TB | |||||
 Pulmonary (368) | 73 (96.05) | 295 (96.72) | 0.824 | 0.7 | 0.221–3.073 |
 Extra-pulmonary (13) | 3 (3.95) | 10 (3.28) |  |  |  |
History of TB | |||||
 New cases (247) | 39 (51.32) | 202 (66.23) | 0.537 | 0.01 | 0.323–0.894 |
 Previously treated (134) | 37 (48.68) | 103 (33.77) |  |  | |
Drug resistance | |||||
 Any drug resistance (194) | 50 (65.79) | 144 (47.21) | 2.15 |  | 1.272– |
 Susceptible to all (R + H+ S + E) (187) | 26 (34.21) | 161 (52.79) |  | 0.004 | 3.633 |
 MDR (121) | 45 (59.21) | 76 (24.92) | 0.586 | 0.032 | 0.359–0.956 |
Total Cases (381) | 76 (19.95) | 305 (80.05) | – | – | – |